Inhibition of protein kinase CK2 leads to a modulation of androgen receptor dependent transcription in prostate cancer cells

Prostate - Tập 67 Số 2 - Trang 125-134 - 2007
Claudia Götz1, Christa Bachmann1, Mathias Montenarh1
1Universität des Saarlandes, Medizinische Biochemie und Molekularbiologie, Homburg, Germany

Tóm tắt

AbstractBACKGROUNDThe androgen receptor (AR) mediates the biological responses of androgens in the prostate gland. In prostate cancer, this pathway is often deregulated and causes an uncontrolled proliferation.METHODSThe current study focuses on the effects of an inhibition of protein kinase CK2 on the AR‐mediated transcription in LNCaP prostate cancer cells. We used chemical inhibitors of CK2 as well as dominant‐negative kinase mutants to downregulate the CK2 activity. We determined the effects of the inhibition by Western blot analysis of endogenous target genes of the AR as well as by reporter assays.RESULTSWe found that inhibition of CK2 led to a downregulation of the AR‐dependent transcription. Moreover, the amount of the AR protein decreased significantly.CONCLUSIONAccording to the fact that AR pathways are involved in the development and progression of prostate cancer, the ability to modulate AR function should provide an alternative basis for the development of new cancer therapies. Prostate © 2006 Wiley‐Liss, Inc.

Từ khóa


Tài liệu tham khảo

10.1210/edrv-16-3-271

10.1210/me.7.11.1418

10.1016/S0960-0760(99)00049-7

10.1210/mend-5-12-1921

10.1074/jbc.M111962200

Gao X, 1995, Tumor suppressor genes and their involvment in human prostate cancer, Cancer Molec Biol, 2, 475

10.1038/sj.cgt.7700202

Geiger T, 1997, Antitumor activity of a C‐raf antisense oligonucleotide in combination with standard chemotherapeutic agents against various human tumors transplanted subcutaneously into nude mice, Clin Cancer Res, 3, 1179

10.1055/s-1999-13953

10.1016/S0014-5793(01)02404-8

10.1042/bj20021469

10.1096/fasebj.9.5.7896000

10.1096/fj.02-0473rev

10.1016/S0301-0082(99)00026-X

10.1128/MCB.10.8.4089

10.1016/S0021-9258(17)37471-9

10.1038/sj.onc.1204665

10.1002/1097-4644(2000)79:35 <130::AID-JCB1136>3.0.CO;2-N

10.1016/0304-3835(96)04110-9

10.1038/sj.onc.1201854

10.1074/jbc.M004862200

10.1042/bj3640041

Krippner‐Heidenreich A, 2001, Targeting of the transcription factor Max during apoptosis: Phosphorylation‐regulated cleavage by caspase‐5 at an unusual glutamic acid residue in position P1, Biochem J, 358, 705, 10.1042/bj3580705

10.1016/0006-291X(84)90297-3

Horoszewicz JS, 1983, LNCaP model of human prostatic carcinoma, Cancer Res, 43, 1809

10.1038/227680a0

10.1016/S0014-5793(99)01492-1

10.1089/hyb.1995.14.335

10.1073/pnas.82.3.737

10.1074/jbc.271.11.6379

10.1002/(SICI)1097-4644(19970315)64:4<525::AID-JCB1>3.0.CO;2-T

10.1074/jbc.M204131200

10.1210/me.9.5.605

10.3109/07853899309147863

Miyata Y, 2002, The 90‐kDa heat shock protein, HSP90, binds and protects casein kinase II from self‐aggregation and enhances its kinase activity, J Biol Chem, 267, 7042, 10.1016/S0021-9258(19)50533-6

10.1073/pnas.94.26.14500

10.1074/jbc.M212260200

10.1158/0008-5472.CAN-04-3250

Hessenauer A, 2003, CK2‐mediated pathways are interrupted in hormone‐refractory prostate carcinoma cell lines, Int J Oncol, 22, 1263

Thông tin
Thông tin xuất bản

Prostate

Tập 67 Số 2

125-134

Thông tin tác giả